Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Canada · Delayed Price · Currency is CAD

0.9700

-0.0200 (-2.02%)

Jul 31, 2026, 3:56 PM EST

125.58% (1Y)

Market Cap	66.82M +125.6%
Revenue (ttm)	787.78K +19.8%
Net Income	-221.79K
EPS	-0.00
Shares Out	68.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,430
Open	0.9800
Previous Close	0.9900
Day's Range	0.9600 - 1.0000
52-Week Range	0.3000 - 1.1000
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 25, 2026

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for bones, teeth, and health; Eleotin G2000 for c... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2010

Country Canada

Stock Exchange TSX Venture Exchange

Ticker Symbol EBM

Full Company Profile

Financial Performance

In fiscal year 2025, TSXV:EBM's revenue was 782,080, an increase of 11.40% compared to the previous year's 702,076. Losses were -332,767, -27.00% less than in 2024.

Financial Statements